Literature DB >> 16160170

Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.

J T Gerlach1, A Ulsenheimer, N H Grüner, M-C Jung, W Schraut, C-A Schirren, M Heeg, S Scholz, K Witter, R Zahn, A Vogler, R Zachoval, G R Pape, H M Diepolder.   

Abstract

The hepatitis C virus (HCV)-specific CD4+ T-cell response against nonstructural proteins is strongly associated with successful viral clearance during acute hepatitis C. To further develop these observations into peptide-based vaccines and clinical immunomonitoring tools like HLA class II tetramers, a detailed characterization of immunodominant CD4+ T-cell epitopes is required. We studied peripheral blood mononuclear cells from 20 patients with acute hepatitis C using 83 overlapping 20-mer peptides covering the NS3 helicase and NS4. Eight peptides were recognized by > or = 40% of patients, and specific CD4+ T-cell clones were obtained for seven of these and three additional, subdominant epitopes. Mapping of minimal stimulatory sequences defined epitopes of 8 to 13 amino acids in length, but optimal T-cell stimulation was observed with 10- to 15-mers. While some epitopes were presented by different HLA molecules, others were presented by only a single HLA class II molecule, which has implications for patient selection in clinical trials of peptide-based immunotherapies. In conclusion, using two different approaches we identified and characterized a set of CD4+ T-cell epitopes in the HCV NS3-NS4 region which are immunodominant in patients achieving transient or persistent viral control. This information allows the construction of a valuable panel of HCV-specific HLA class II tetramers for further study of CD4+ T-cell responses in chronic hepatitis C. The finding of immunodominant epitopes with very constrained HLA restriction has implications for patient selection in clinical trials of peptide-based immunotherapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160170      PMCID: PMC1211510          DOI: 10.1128/JVI.79.19.12425-12433.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.

Authors:  A Godkin; N Jeanguet; M Thursz; P Openshaw; H Thomas
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

2.  Definition of supertypes for HLA molecules using clustering of specificity matrices.

Authors:  Ole Lund; Morten Nielsen; Can Kesmir; Anders Gorm Petersen; Claus Lundegaard; Peder Worning; Christina Sylvester-Hvid; Kasper Lamberth; Gustav Røder; Sune Justesen; Søren Buus; Søren Brunak
Journal:  Immunogenetics       Date:  2004-02-13       Impact factor: 2.846

Review 3.  Hepatitis C virus infection in the United States.

Authors:  M J Alter
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

4.  Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.

Authors:  J T Gerlach; H M Diepolder; M C Jung; N H Gruener; W W Schraut; R Zachoval; R Hoffmann; C A Schirren; T Santantonio; G R Pape
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

5.  Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.

Authors:  Amalia Penna; Gabriele Missale; Vincenzo Lamonaca; Massimo Pilli; Cristina Mori; Paola Zanelli; Albertina Cavalli; Gianfranco Elia; Carlo Ferrari
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

6.  Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection.

Authors:  Cheryl L Day; Georg M Lauer; Gregory K Robbins; Barbara McGovern; Alysse G Wurcel; Rajesh T Gandhi; Raymond T Chung; Bruce D Walker
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 7.  Clinical significance of hepatitis C virus genotypes and quasispecies.

Authors:  P Farci; R H Purcell
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

8.  Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection.

Authors:  Anne M Wertheimer; Camette Miner; David M Lewinsohn; Anna W Sasaki; Ezra Kaufman; Hugo R Rosen
Journal:  Hepatology       Date:  2003-03       Impact factor: 17.425

9.  Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes.

Authors:  G C Harcourt; M Lucas; I Sheridan; E Barnes; R Phillips; P Klenerman
Journal:  J Viral Hepat       Date:  2004-07       Impact factor: 3.728

10.  Determinants of viral clearance and persistence during acute hepatitis C virus infection.

Authors:  R Thimme; D Oldach; K M Chang; C Steiger; S C Ray; F V Chisari
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

View more
  22 in total

1.  Three-dimensional structure determines the pattern of CD4+ T-cell epitope dominance in influenza virus hemagglutinin.

Authors:  Samuel J Landry
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

2.  Extensive HLA class I allele promiscuity among viral CTL epitopes.

Authors:  Nicole Frahm; Karina Yusim; Todd J Suscovich; Sharon Adams; John Sidney; Peter Hraber; Hannah S Hewitt; Caitlyn H Linde; Daniel G Kavanagh; Tonia Woodberry; Leah M Henry; Kellie Faircloth; Jennifer Listgarten; Carl Kadie; Nebojsa Jojic; Kaori Sango; Nancy V Brown; Eunice Pae; M Tauheed Zaman; Florian Bihl; Ashok Khatri; Mina John; Simon Mallal; Francesco M Marincola; Bruce D Walker; Alessandro Sette; David Heckerman; Bette T Korber; Christian Brander
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

3.  Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation.

Authors:  Peter A Sieling; Preston J Hill; Karen M Dobos; Kerry Brookman; Andrew M Kuhlman; Mario Fabri; Stephan R Krutzik; Thomas H Rea; Darragh G Heaslip; John T Belisle; Robert L Modlin
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

Review 4.  On the cutting edge: protease-based methods for sensing and controlling cell biology.

Authors:  H Kay Chung; Michael Z Lin
Journal:  Nat Methods       Date:  2020-07-13       Impact factor: 28.547

5.  Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cells.

Authors:  Mélanie Lambotin; Thomas F Baumert; Heidi Barth
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

6.  CD4+ T-cell epitope prediction using antigen processing constraints.

Authors:  Ramgopal R Mettu; Tysheena Charles; Samuel J Landry
Journal:  J Immunol Methods       Date:  2016-02-15       Impact factor: 2.303

7.  Synthetic antigens representing the antigenic variation of human hepatitis C virus.

Authors:  Kyung Hee Kang; Yasuhiro Yamamura; Maria P Carlos; Nicolas Karvelas; In-Sup Kim; Deepa Sunkara; Rebecca Rivera; Murray B Gardner; David E Anderson; Francisco Diaz-Mitoma; José Torres; Juan P Marquez
Journal:  Viral Immunol       Date:  2010-10       Impact factor: 2.257

8.  Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection.

Authors:  Julian Schulze Zur Wiesch; Georg M Lauer; Joerg Timm; Thomas Kuntzen; Martin Neukamm; Andrew Berical; Andrea M Jones; Brian E Nolan; Steve A Longworth; Victoria Kasprowicz; Cory McMahon; Alysse Wurcel; Ansgar W Lohse; Lia L Lewis-Ximenez; Raymond T Chung; Arthur Y Kim; Todd M Allen; Bruce D Walker
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

Review 9.  CD4+ T cell responses in hepatitis C virus infection.

Authors:  Nasser Semmo; Paul Klenerman
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 10.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.